AzTrials
AzTrials

Nasopharyngeal Carcinoma (NPC)NCT07909538

The Effectiveness of Structured Swallowing Exercise Therapy in Patients With Nasopharyngeal Carcinoma: An Assessment of Swallowing Function and Quality of Life

A study testing Structured Swallowing Exercise and Conventional Swallowing Exercise in people with Nasopharyngeal Carcinoma (NPC), run by Ira Mistivani, dr. Sp.KFR.N.M.(K). at 1 site in Indonesia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of a structured swallowing exercise program compared with conventional swallowing exercises in patients with nasopharyngeal carcinoma. Read more about this study

Who is it for?
Ages 18 to 59 years
Conditions the study is for
Nasopharyngeal Carcinoma (NPC)
What is being tested?
Structured Swallowing Exercise and Conventional Swallowing Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteIndonesia
Study dates
9 Sep 2026to 31 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with histologically confirmed nasopharyngeal carcinoma.
  • Age 18 to less than 60 years.
  • Male or female.
  • Mini-Mental State Examination (MMSE) score of 25-30.
  • Hemodynamically stable.
  • Non-metastatic nasopharyngeal carcinoma.
Show all 10Show fewer
  • Gugging Swallowing Screen (GUSS) score of 0-20.
  • Penetration-Aspiration Scale (PAS) score of ≥1 on videofluoroscopic swallowing study (VFSS).
  • Able to undergo VFSS using International Dysphagia Diet Standardisation Initiative (IDDSI) Level 0 and Level 3 consistencies, with or without a nasogastric tube.
  • Willing and able to provide written informed consent.

Who cannot join

  • History of stroke.
  • Parkinson's disease.
  • Myasthenia gravis.
  • Other head and neck cancer, except nasopharyngeal carcinoma.
  • Esophageal cancer.
  • History of traumatic brain injury.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ira Mistivani, Sp.KFR.N.M.(K) contact

+62 852 8626 3688

ira.mistivani41@ui.ac.id

Indonesia1 site, 1 recruiting
  • RSUPN Dr. Cipto Mangunkusumo (RSCM)

    Jakarta Pusat, DKI Jakarta

    Ira Mistivani, Sp.KFR.N.M.(K), +62 852 8626 3688, ira.mistivani41@ui.ac.id

    Ira Mistivani, Sp.KFR.N.M.(K)

    Recruiting

Other trials in Indonesia

About this study

This study aims to evaluate the effectiveness of a structured swallowing exercise program compared with conventional swallowing exercises in patients with nasopharyngeal carcinoma. The study will assess changes in swallowing function, swallowing biomechanics, airway safety, and quality of life following the intervention.

Read the detailed description

Nasopharyngeal carcinoma is associated with swallowing dysfunction, which may affect swallowing safety, swallowing biomechanics, nutritional status, and quality of life. Early swallowing rehabilitation or prehabilitation may help maintain and improve swallowing function during cancer treatment.

This study is a randomized controlled trial designed to evaluate the effectiveness of a structured swallowing exercise program compared with conventional swallowing exercises in patients with nasopharyngeal carcinoma.

Eligible participants will be randomly assigned to either the structured swallowing exercise group or the conventional swallowing exercise group. The intervention will be conducted for 8 weeks.

Swallowing function will be evaluated using the Gugging Swallowing Screen (GUSS), penetration-aspiration scale (PAS), and videofluoroscopic swallowing study (VFSS). Hyolaryngeal excursion will be assessed using VFSS analysis. Health-related quality of life related to head and neck symptoms and swallowing will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Module 35 (EORTC QLQ-H\&N35).

GUSS will be assessed at baseline, week 4, and week 8. PAS, hyolaryngeal excursion, and EORTC QLQ-H\&N35 will be assessed at baseline and at week 8. The study will compare changes in swallowing function, swallowing biomechanics, airway safety, and quality of life between the two intervention groups.

Being tested
Structured Swallowing Exercise, Conventional Swallowing Exercise
Keywords
Nasopharyngeal Carcinoma, Dysphagia, Swallowing rehabilitation, Swallowing exercise, Swallowing function, Videofluoroscopic swallowing study, Hyolaryngeal excursion, Quality of life
Medical subject headings
Nasopharyngeal Carcinoma, Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured Swallowing ExerciseBehavioural

    The structured swallowing exercise program is a multimodal, systematic, and progressive swallowing rehabilitation program consisting of Isometric Neck Flexion-Extension Exercise, Jaw Opening Exercise, Jaw Range of Motion Exercise, Tongue Range of Motion Exercise, Chin Tuck Against Resistance (CTAR), Mendelsohn Maneuver, and Diaphragmatic Breathing Exercise. The exercises are organized progressively into preparation, strengthening, coordination, and functional phases. The program is delivered for 30 minutes per session, twice weekly at the hospital for 8 weeks, with additional home exercises three times weekly. Individual modifications may be made according to the participant's clinical condition, and adherence is monitored through an exercise logbook and periodic supervision.

  • Conventional Swallowing ExerciseBehavioural

    The conventional swallowing exercise program consists of Chin Tuck Against Resistance (CTAR) and Isometric Neck Flexion-Extension Exercise, primarily targeting suprahyoid and anterior cervical muscle strengthening and hyolaryngeal excursion. CTAR includes 3 cycles of 60-second isometric exercise and 2 cycles of 30 repetitions of isotonic exercise, repeated for 3 sets per day. Isometric Neck Flexion-Extension Exercise consists of resisted neck flexion and extension, with each contraction maintained for 5-10 seconds, performed in 3 sets per day with 10-15 repetitions per set. The program is delivered for 30 minutes per session, twice weekly at the hospital for 8 weeks, with additional home exercises three times weekly. Adherence is monitored during the study.

Study groups in NCT07909538
Study groupRoleWhat they receive
Conventional Swallowing ExerciseActive comparatorParticipants randomized to this arm will receive a conventional swallowing exercise program for 8 weeks. The program consists of conventional swallowing rehabilitation exercises aimed at maintaining and improving swallowing function and swallowing biomechanics in patients with nasopharyngeal carcinoma.
Receives: Behavioral: Conventional Swallowing Exercise
Structured Swallowing ExerciseExperimentalParticipants randomized to this arm will receive a structured swallowing exercise program for 8 weeks. The program is designed as a structured swallowing rehabilitation intervention to maintain and improve swallowing function, swallowing biomechanics, airway safety, and swallowing-related quality of life in patients with nasopharyngeal carcinoma.
Receives: Behavioral: Structured Swallowing Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Hyolaryngeal Excursion from Baseline to Week 8

    Hyolaryngeal excursion (HLE) assessed during VFSS by frame-by-frame analysis of hyoid bone displacement during swallowing. HLE is calculated from the anterior and superior displacement of the hyoid bone between its resting position and maximal elevation during swallowing and expressed in millimeters (mm). The outcome will be assessed as the change in HLE from baseline to week 8, with greater excursion indicating greater hyolaryngeal movement.

    Measured: Baseline and Week 8

  2. Change in Penetration-Aspiration Scale (PAS) Score from Baseline to Week 8

    Penetration-Aspiration Scale (PAS) score assessed during videofluoroscopic swallowing study (VFSS) to evaluate airway penetration and aspiration during swallowing. The PAS is an 8-point scale, ranging from 1 to 8, with higher scores indicating more severe airway invasion. The outcome will be assessed as the change in PAS score from baseline to week 8.

    Measured: Baseline and Week 8

  3. Change in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35 (EORTC QLQ-H&N35) Score from Baseline to Week 8

    Health-related quality of life assessed using the validated Indonesian version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35 (EORTC QLQ-H\&N35). The questionnaire assesses symptoms and problems related to head and neck cancer, including swallowing, eating, social contact, dry mouth, thick saliva, pain, speech, and other disease- or treatment-related symptoms. Scores are transformed to a 0-100 scale, with higher scores indicating greater symptom burden or problems and therefore worse symptom-related quality of life. The outcome will be assessed as the change in score from baseline to week 8.

    Measured: Baseline and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study start9 Sep 2026
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
88 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07909538
Sponsor's protocol ID
26-07-1181
Status last verified
Oct 2026
First submitted
21 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rahmaeni R; Kuhuwael F; Rahardjo SP; Validitas dan reliabilitas EORTC QLQ-H&N35 sebagai alat ukur kualitas hidup penderita kanker kepala leher; Oto Rhino Laryngologica Indonesiana; December 2015; 45(2); 142-150.

  • Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology (Williston Park). 1997 May;11(5):651-6, 659; discussion 659, 663-4.

    PubMed 9159792
  • McCullough GH, Kim Y. Effects of the Mendelsohn maneuver on extent of hyoid movement and UES opening post-stroke. Dysphagia. 2013 Dec;28(4):511-9. doi: 10.1007/s00455-013-9461-1. Epub 2013 Mar 14.

    PubMed 23494471
  • Kraaijenga SAC, Molen LV, Stuiver MM, Takes RP, Al-Mamgani A, Brekel MWMVD, Hilgers FJM. Efficacy of a novel swallowing exercise program for chronic dysphagia in long-term head and neck cancer survivors. Head Neck. 2017 Oct;39(10):1943-1961. doi: 10.1002/hed.24710. Epub 2017 Aug 2.

    PubMed 28766850
  • Yoon WL, Khoo JK, Rickard Liow SJ. Chin tuck against resistance (CTAR): new method for enhancing suprahyoid muscle activity using a Shaker-type exercise. Dysphagia. 2014 Apr;29(2):243-8. doi: 10.1007/s00455-013-9502-9. Epub 2013 Dec 15.

    PubMed 24337867
  • Brates D, Molfenter SM, Thibeault SL. Assessing Hyolaryngeal Excursion: Comparing Quantitative Methods to Palpation at the Bedside and Visualization During Videofluoroscopy. Dysphagia. 2019 Jun;34(3):298-307. doi: 10.1007/s00455-018-9927-2. Epub 2018 Jul 24.

    PubMed 30043080
  • Sia I, Carvajal P, Carnaby-Mann GD, Crary MA. Measurement of hyoid and laryngeal displacement in video fluoroscopic swallowing studies: variability, reliability, and measurement error. Dysphagia. 2012 Jun;27(2):192-7. doi: 10.1007/s00455-011-9352-2. Epub 2011 Jul 7.

    PubMed 21735182
  • Alkhuwaiter M, Davidson K, Hopkins-Rossabi T, Martin-Harris B. Scoring the Penetration-Aspiration Scale (PAS) in Two Conditions: A Reliability Study. Dysphagia. 2022 Apr;37(2):407-416. doi: 10.1007/s00455-021-10292-6. Epub 2021 Apr 21.

    PubMed 33880656
  • Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hicsonmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioglu U, Demiral AN, Hayran M. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1347-53. doi: 10.1016/j.ijrobp.2005.05.057. Epub 2005 Sep 19.

    PubMed 16169671
  • Baudelet M, Van den Steen L, Duprez F, Goeleven A, Nuyts S, Nevens D, Vandenbruaene C, Massonet H, Vergauwen A, Vauterin T, Verstraete H, Wouters K, Vanderveken O, De Bodt M, Van Nuffelen G; members of the Belgian PRESTO-group. Prophylactic Swallowing Therapy During Head-and-Neck Cancer Radiotherapy: Effect of Service-Delivery Mode and Overall Adherence Level on Swallowing Function and Muscle Strength-the PRESTO Trial. Dysphagia. 2024 Apr;39(2):267-281. doi: 10.1007/s00455-023-10609-7. Epub 2023 Aug 8.

    PubMed 37550571
  • Hajdu SF, Wessel I, Dalton SO, Eskildsen SJ, Johansen C. Swallowing Exercise During Head and Neck Cancer Treatment: Results of a Randomized Trial. Dysphagia. 2022 Aug;37(4):749-762. doi: 10.1007/s00455-021-10320-5. Epub 2021 Jun 11.

    PubMed 34117531
  • Ku PKM, Vlantis AC, Wong RWM, Hui TSC, Law T, Ng LKY, Wong EWY, Chang WT, Johnson DR, Mok FST, Wong KH, Abdullah V, van Hasselt A, Lee KYS, Tong MCF. Quality of life and swallowing outcomes after early proactive swallowing rehabilitation by either transcutaneous neuromuscular electrical stimulation or exercise-based swallowing training in patients with nasopharyngeal carcinoma after radiotherapy. Laryngoscope Investig Otolaryngol. 2023 Oct 14;8(6):1532-1546. doi: 10.1002/lio2.1162. eCollection 2023 Dec.

    PubMed 38130249

Questions about this trial

What is this clinical trial studying?

A study testing Structured Swallowing Exercise and Conventional Swallowing Exercise in people with Nasopharyngeal Carcinoma (NPC), run by Ira Mistivani, dr. Sp.KFR.N.M.(K). at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ira Mistivani, Sp.KFR.N.M.(K) (+62 852 8626 3688, ira.mistivani41@ui.ac.id), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Hyolaryngeal Excursion from Baseline to Week 8 (time frame: Baseline and Week 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07909538, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in